DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr | ₹1,413 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹2,156 Cr |
Mar2023 | ₹1,793 Cr |
Mar2022 | ₹2,424 Cr |
Mar2021 | ₹1,677 Cr |
Mar2020 | ₹1,413 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹2,156 Cr | 20.25 | |
Mar2023 | ₹1,793 Cr | -26.03 | |
Mar2022 | ₹2,424 Cr | 44.58 | |
Mar2021 | ₹1,677 Cr | 18.62 | |
Mar2020 | ₹1,413 Cr | - |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹183,289.3 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics | |
MANKIND PHARMA | ₹100,677.0 Cr | 5% | 3.3% | 11% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.4% |
4.1% |
50.3% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses